Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    24005123 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Cognitive Therapy Versus Medication Treatment for Preventing Depression Relapse
Condition: Depression
Interventions: Drug: Fluoxetine (Prozac);   Behavioral: Cognitive therapy (CT);   Drug: Placebo
2 Terminated Cognitive Therapy for Treating Depression and Preventing Relapse
Condition: Depression
Interventions: Drug: Fluoxetine;   Behavioral: Cognitive therapy (CT);   Drug: Placebo
3 Completed
Has Results
Cognitive Therapy for Recurrent Depression
Condition: Depression
Interventions: Behavioral: Continuation phase cognitive therapy;   Drug: Continuation phase fluoxetine;   Other: Continuation phase pill placebo;   Behavioral: Acute phase cognitive therapy

Indicates status has not been verified in more than two years